GT201400115A - Combinación farmacéutica antineurítica y composición - Google Patents
Combinación farmacéutica antineurítica y composiciónInfo
- Publication number
- GT201400115A GT201400115A GT201400115A GT201400115A GT201400115A GT 201400115 A GT201400115 A GT 201400115A GT 201400115 A GT201400115 A GT 201400115A GT 201400115 A GT201400115 A GT 201400115A GT 201400115 A GT201400115 A GT 201400115A
- Authority
- GT
- Guatemala
- Prior art keywords
- antineurítica
- composición
- pharmaceutical combination
- combinations
- pharmaceutical
- Prior art date
Links
- 229940088594 vitamin Drugs 0.000 abstract 2
- 229930003231 vitamin Natural products 0.000 abstract 2
- 235000013343 vitamin Nutrition 0.000 abstract 2
- 239000011782 vitamin Substances 0.000 abstract 2
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 229960003965 antiepileptics Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A COMBINACIONES FARMACÉUTICAS DE DOS ANTIEPILÉPTICOS, ASÍ COMO COMBINACIONES DE UN ANTIEPILÉPTICO, Y VITAMINAS DEL COMPLEJO B, EN DONDE LOS ANTIEPILÉPTICOS SE SELECCIONAN DE PREGABALINA Y OXCARBAZEPINA, Y LAS VITAMINAS SE SELECCIONAN DE VITAMINA B1 Y VITAMINA B12. TAMBIÉN SE REFIERE A COMPOSICIONES FARMACÉUTICAS QUE CONTIENEN DICHAS COMBINACIONES Y AL USO DE DICHAS COMPOSICIONES PARA EL TRATAMIENTO DEL DOLOR NEUROPÁTICO (DN).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2011014042A MX336979B (es) | 2011-12-16 | 2011-12-16 | Combinacion farmaceutica antineuritica y composiciones. |
Publications (1)
Publication Number | Publication Date |
---|---|
GT201400115A true GT201400115A (es) | 2017-07-27 |
Family
ID=48611941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT201400115A GT201400115A (es) | 2011-12-16 | 2014-06-16 | Combinación farmacéutica antineurítica y composición |
Country Status (14)
Country | Link |
---|---|
US (1) | US20140323428A1 (es) |
BR (1) | BR112014014774A2 (es) |
CA (1) | CA2859487C (es) |
CL (1) | CL2014001581A1 (es) |
CO (1) | CO6990712A2 (es) |
CR (1) | CR20140283A (es) |
DO (1) | DOP2014000134A (es) |
ES (1) | ES2525952B1 (es) |
GT (1) | GT201400115A (es) |
MX (1) | MX336979B (es) |
NI (1) | NI201400058A (es) |
PE (1) | PE20141688A1 (es) |
PL (1) | PL231163B1 (es) |
WO (1) | WO2013088410A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2826470B1 (en) * | 2013-07-19 | 2017-09-06 | Arven Ilac Sanayi ve Ticaret A.S. | Pharmaceutical combinations of pregabalin |
MX2014008336A (es) | 2014-07-07 | 2016-01-07 | Pptm Internat S A R L | Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070007276A (ko) * | 2003-12-29 | 2007-01-15 | 제이슨 맥데빗 | 재발성 의학적 증상을 치료하기 위한 조성물 및 방법 |
CA2701838A1 (en) * | 2007-10-09 | 2009-04-16 | Merck Patent Gmbh | Pharmaceutical compositions containing benfotiamine and one or more pharmaceutically active agents for the treatment of pain conditions of neuropathic origin |
US8394759B2 (en) * | 2008-11-21 | 2013-03-12 | Cymbiotics, Inc. | Transdermal delivery of medicaments with combinations of cetylated fatty ester penetrant complexes |
-
2011
- 2011-12-16 MX MX2011014042A patent/MX336979B/es active IP Right Grant
-
2012
- 2012-12-14 US US14/365,988 patent/US20140323428A1/en not_active Abandoned
- 2012-12-14 ES ES201490063A patent/ES2525952B1/es not_active Expired - Fee Related
- 2012-12-14 PL PL409542A patent/PL231163B1/pl unknown
- 2012-12-14 BR BR112014014774A patent/BR112014014774A2/pt not_active Application Discontinuation
- 2012-12-14 PE PE2014000973A patent/PE20141688A1/es active IP Right Grant
- 2012-12-14 CA CA2859487A patent/CA2859487C/en active Active
- 2012-12-14 WO PCT/IB2012/057345 patent/WO2013088410A1/es active Application Filing
-
2014
- 2014-06-16 CL CL2014001581A patent/CL2014001581A1/es unknown
- 2014-06-16 CO CO14129791A patent/CO6990712A2/es unknown
- 2014-06-16 DO DO2014000134A patent/DOP2014000134A/es unknown
- 2014-06-16 NI NI201400058A patent/NI201400058A/es unknown
- 2014-06-16 CR CR20140283A patent/CR20140283A/es unknown
- 2014-06-16 GT GT201400115A patent/GT201400115A/es unknown
Also Published As
Publication number | Publication date |
---|---|
US20140323428A1 (en) | 2014-10-30 |
ES2525952A1 (es) | 2015-01-02 |
CO6990712A2 (es) | 2014-07-10 |
PE20141688A1 (es) | 2014-12-03 |
CA2859487C (en) | 2016-11-15 |
MX2011014042A (es) | 2013-06-17 |
CL2014001581A1 (es) | 2014-09-26 |
PL409542A1 (pl) | 2015-07-20 |
CA2859487A1 (en) | 2013-06-20 |
NI201400058A (es) | 2014-12-22 |
ES2525952B1 (es) | 2015-10-05 |
DOP2014000134A (es) | 2014-07-31 |
WO2013088410A1 (es) | 2013-06-20 |
BR112014014774A2 (pt) | 2017-06-13 |
CR20140283A (es) | 2015-03-11 |
MX336979B (es) | 2016-02-09 |
PL231163B1 (pl) | 2019-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20150326A (es) | Inhibidores de autotaxina | |
GT201700189A (es) | Derivados de nucleósidos sustituidos útiles como agentes antineoplásicos | |
NI201600144A (es) | Derivados de quinoxalina utiles como moduladores del fgfr cinasa | |
SV2018005687A (es) | Derivados de dihidroimidazopirazinona usados en el tratamiento del cancer | |
CL2013001338A1 (es) | Compuestos derivados de benzotieno-piridinas sustituidas, inhibidores de la replicacion del vih; composicion farmaceutica que los comprende; combinacion farmaceutica; kit farmaceutico; y su uso para el tratamiento del vih. | |
CL2014001829A1 (es) | Compuestos derivados de indolizina; procedimiento de preparación; composiciones farmacéuticas que los contienen y uso en el tratamiento del cancer. | |
CL2015001437A1 (es) | Derivados de pirimidin-2,4-diamina para el tratamiento de cancer | |
CL2014001793A1 (es) | Compuestos derivados de 1,3,5-triazinas sustituidas y sus sales, como inhibidores de la idh2 mutante; composicion farmaceutica que los comprende; y su uso para el tratamiento del cancer. | |
CL2014001865A1 (es) | Compuestos derivados de fosfatos; procedimiento de preparacion; composiciones farmaceuticas que los contienen y uso en el tratamiento del cancer. | |
CL2016000063A1 (es) | Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen. | |
DOP2018000062A (es) | Piridinona dicaboxamidas para uso como inhibidores de bromodominio | |
BR112016028845A2 (pt) | composto, composição farmacêutica e uso de um composto | |
CL2017002170A1 (es) | Desacetoxitubulisina h y análogos de esta. | |
DOP2016000253A (es) | Nuevos compuestos | |
CO2019012767A2 (es) | Compuesto de fenil-2-hidroxi-acetilamino-2-metil-fenilo | |
CO2017002472A2 (es) | Formulación de acetato de abiraterona | |
SV2017005412A (es) | Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos | |
DOP2016000212A (es) | Heterociclos condensados sustituidos como moduladores de gpr119 para el tratamiento de la diabetes, obesidad, dislipidemia y trastornos relacionados | |
ECSP14014778A (es) | Composiciones derivadas de la quitosana | |
DOP2015000005A (es) | Derivados de estra 1,3,5(10), 16 tetraeno 3 sustituidos, métodos para su preparación, preparaciones farmacéuticas que los contienen, así como su uso para la preparación de medicamentos | |
SV2017005466A (es) | Pirazolpiridinaminas como inhibidores de mknk1 y mknk2 | |
BR112017022158A2 (pt) | compostos, composições farmacêuticas e uso de um composto | |
CL2017000587A1 (es) | Derivados de tetrahidroquinolina como inhibidores de bromodominio | |
CR20160529A (es) | Composiciones farmacéuticas para tratar enfermedades infecciosas | |
PE20150167A1 (es) | (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel |